Patent · US Active

Methods of treating attention deficit hyperactivity disorder

US9949931B2 · kind B2 · utility

0Cited by

36References

23Claims

0Family size

Assignee

Rhodes Pharmaceuticals L.P. · US

Inventors

Thinnayam N. Krishnamurthy · Scarborough, CA
Andrew Darke · Schreiber, CA

Key dates

Filing date	Nov 4, 2016
Grant date	Apr 24, 2018
Priority date	—
Expiry date	Nov 4, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration is lower than that provided by the reference standard for immediate release formulations of the drug, and the duration of effect falls rapidly at the end of the dosing interval.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.